Regulations.gov document
Letter from BioNeutra North America Inc. to FDA DDM
Other · FDA-2016-P-4275 · posted Apr 20, 2017
Key facts
| Document ID | FDA-2016-P-4275-0054 |
|---|---|
| Title | Letter from BioNeutra North America Inc. to FDA DDM |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2016-P-4275 |
| Posted | Apr 20, 2017 |
| Comment period opens | Apr 20, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: